Related references
Note: Only part of the references are listed.Antiplatelet Drug Response Variability and the Role of Platelet Function Testing: A Practical Guide for Interventional Cardiologists
Dominick J. Angiolillo et al.
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS (2009)
High Residual Platelet Reactivity After Clopidogrel Loading and Long-Term Clinical Outcome After Drug-Eluting Stenting for Unprotected Left Main Coronary Disease
Angela Migliorini et al.
CIRCULATION (2009)
Cytochrome P-450 Polymorphisms and Response to Clopidogrel.
Jessica L. Mega et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Genetic Determinants of Response to Clopidogrel and Cardiovascular Events.
Tabassome Simon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Immediate and long-term outcomes of drug-eluting stent implantation for unprotected left main coronary artery disease: Comparison with bare-metal stent implantation
Run-lin Gao et al.
AMERICAN HEART JOURNAL (2008)
CYP2C19 and nongenetic factors predict poor responsiveness to clopidogrel loading dose after coronary stent implantation
Tobias Geisler et al.
PHARMACOGENOMICS (2008)
Clopidogrel resistance: Role of body mass and concomitant medications
Gergely Feher et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2007)
Variability in individual responsiveness to clopidogrel - Clinical implications, management, and future perspectives
Dominick J. Angiolillo et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Aspirin and clopidogrel resistance: an emerging clinical entity
TH Wang et al.
EUROPEAN HEART JOURNAL (2006)
Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention - The role of dual drug resistance
EI Lev et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Clopidogrel effect on platelet REactivity in patients with stent thrombosis - Results of the CREST study
PA Gurbel et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatment
DJ Angiolillo et al.
DIABETES (2005)
Contribution of hepatic cytochrome P450 3A4 metabolic activity to the phenomenon of clopidogrel resistance
WC Lau et al.
CIRCULATION (2004)
Platelet activation in type 2 diabetes mellitus
P Ferroni et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2004)
Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction
S Matetzky et al.
CIRCULATION (2004)
Resistance to thienopyridines: Clinical detection of coronary stent thrombosis by monitoring of vasodilator-stimulated phosphoprotein phosphorylation
P Barragan et al.
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS (2003)
Clopidogrel for coronary stenting - Response variability, drug resistance, and the effect of pretreatment platelet reactivity
PA Gurbel et al.
CIRCULATION (2003)
Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events
JW Eikelboom et al.
CIRCULATION (2002)
American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes - A report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee)
CP Cannon et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2001)
Share Paper
